Valproate Use In Women and Girls Of Childbearing Years

Guidance for doctors and other healthcare professionals regarding the use of sodium valproate.

This guidance document is intended for doctors and other healthcare professionals across primary and secondary care, regarding the use of sodium valproate.

The advice is based on 2018 regulations issued by the Medicines and Healthcare Products Regulatory Authority (MHRA) around the prescribing and dispensing of valproate. It looks at the more challenging issues that clinicians across primary and specialist care might encounter in daily practice. These include transition from paediatric to adulthood services, competence to consent to treatment, and confidentiality.